Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Sexually Transmitted Diseases

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 65 articles:
HTML format
Text format



Single Articles


    June 2019
  1. LI W, Meng Y, Wang Y, Cheng X, et al
    Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study.
    Gynecol Oncol. 2019 Jun 24. pii: S0090-8258(19)31270.
    PubMed     Text format     Abstract available


  2. DICK S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, et al
    Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
    Gynecol Oncol. 2019 Jun 7. pii: S0090-8258(19)31279.
    PubMed     Text format     Abstract available


  3. ARO K, Nieminen P, Louvanto K, Jakobsson M, et al
    Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
    Gynecol Oncol. 2019 Jun 5. pii: S0090-8258(19)31268.
    PubMed     Text format     Abstract available


    May 2019
  4. WRIGHT TC JR, Stoler MH, Parvu V, Yanson K, et al
    Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >/=21years of age, with ASC-US or LSIL cytology.
    Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31256.
    PubMed     Text format     Abstract available


  5. ANDERSEN B, Christensen BS, Christensen J, Ejersbo D, et al
    HPV-prevalence in elderly women in Denmark.
    Gynecol Oncol. 2019 May 11. pii: S0090-8258(19)31182.
    PubMed     Text format     Abstract available


  6. FOKOM DOMGUE J, Messick C, Milbourne A, Guo M, et al
    Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.
    Gynecol Oncol. 2019;153:266-270.
    PubMed     Text format     Abstract available


    April 2019
  7. LUCIDO CT, Wynja E, Madeo M, Williamson CS, et al
    Innervation of cervical carcinoma is mediated by cancer-derived exosomes.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)31149.
    PubMed     Text format     Abstract available


  8. SWAILES AL, Hossler CE, Kesterson JP
    Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
    Gynecol Oncol. 2019 Apr 14. pii: S0090-8258(19)30499.
    PubMed     Text format     Abstract available


  9. GIULIANO AR, Joura EA, Garland SM, Huh WK, et al
    Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
    Gynecol Oncol. 2019 Apr 11. pii: S0090-8258(19)30488.
    PubMed     Text format     Abstract available


  10. HARPER DM, Nieminen P, Donders G, Einstein MH, et al
    The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5years of follow-up.
    Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30484.
    PubMed     Text format     Abstract available


    March 2019
  11. WRIGHT TC JR, Parvu V, Stoler MH, Kodsi S, et al
    HPV infections and cytologic abnormalities in vaccinated women 21-34years of age: Results from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30126.
    PubMed     Text format     Abstract available


  12. HALL MT, Smith MA, Lew JB, O'Hallahan J, et al
    The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Gynecol Oncol. 2019;152:472-479.
    PubMed     Text format     Abstract available


  13. VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
    Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
    Gynecol Oncol. 2019;152:465-471.
    PubMed     Text format     Abstract available


    February 2019
  14. VASSILAKOS P, Poncet A, Catarino R, Viviano M, et al
    Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
    Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30064.
    PubMed     Text format     Abstract available


    January 2019
  15. NISHIO S, Mikami Y, Tokunaga H, Yaegashi N, et al
    Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
    Gynecol Oncol. 2019 Jan 29. pii: S0090-8258(19)30063.
    PubMed     Text format     Abstract available


  16. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
    Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >/=25years of age, with NILM cytology.
    Gynecol Oncol. 2019 Jan 9. pii: S0090-8258(18)31538.
    PubMed     Text format     Abstract available


  17. WANG J, Du Y, Dong J, Zhou Y, et al
    Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women.
    Gynecol Oncol. 2019 Jan 7. pii: S0090-8258(18)31542.
    PubMed     Text format     Abstract available


  18. SAND FL, Nielsen DMB, Frederiksen MH, Rasmussen CL, et al
    The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2019;152:208-217.
    PubMed     Text format     Abstract available


    December 2018
  19. ZHANG L, Jiang Y, Lu X, Zhao H, et al
    Genomic characterization of cervical cancer based on human papillomavirus status.
    Gynecol Oncol. 2018 Dec 20. pii: S0090-8258(18)31516.
    PubMed     Text format     Abstract available


    November 2018
  20. LEEMAN A, Ebisch RMF, Kasius A, Bosgraaf RP, et al
    Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Gynecol Oncol. 2018;151:311-318.
    PubMed     Text format     Abstract available


  21. FIANO V, Trevisan M, Fasanelli F, Grasso C, et al
    Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
    Gynecol Oncol. 2018;151:319-326.
    PubMed     Text format     Abstract available


  22. SPAANS VM, Scheunhage DA, Barzaghi B, de Kroon CD, et al
    Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma: Pattern A predicts excellent survival.
    Gynecol Oncol. 2018;151:196-201.
    PubMed     Text format     Abstract available


    October 2018
  23. RODRIGUES LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, et al
    Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajos region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Gynecol Oncol. 2018;151:102-110.
    PubMed     Text format     Abstract available


  24. HORNE ZD, Dohopolski MJ, Pradhan D, Bhargava R, et al
    Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.
    Gynecol Oncol. 2018;151:96-101.
    PubMed     Text format     Abstract available


    September 2018
  25. ZHANG L, Xu XQ, Hu SY, Chen F, et al
    Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
    Gynecol Oncol. 2018 Sep 27. pii: S0090-8258(18)31231.
    PubMed     Text format     Abstract available


  26. GHELARDI A, Parazzini F, Martella F, Pieralli A, et al
    SPERANZA project: HPV vaccination after treatment for CIN2.
    Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31163.
    PubMed     Text format    


  27. ZIEBA S, Kowalik A, Zalewski K, Rusetska N, et al
    Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Gynecol Oncol. 2018;150:552-561.
    PubMed     Text format     Abstract available


    June 2018
  28. ROGERI CD, Silveira HCS, Causin RL, Villa LL, et al
    Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30990.
    PubMed     Text format     Abstract available


  29. STOLER MH, Wright TC Jr, Parvu V, Vaughan L, et al
    The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.
    Gynecol Oncol. 2018;149:498-505.
    PubMed     Text format     Abstract available


    May 2018
  30. STOLNICU S, Barsan I, Hoang L, Patel P, et al
    Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Gynecol Oncol. 2018 May 30. pii: S0090-8258(18)30848.
    PubMed     Text format     Abstract available


  31. TRIMBLE CL
    Towards identifying new therapeutic targets in cancers attributable to HPV.
    Gynecol Oncol. 2018;149:225-226.
    PubMed     Text format    


  32. HINTEN F, Molijn A, Eckhardt L, Massuger LFAG, et al
    Vulvar cancer: Two pathways with different localization and prognosis.
    Gynecol Oncol. 2018;149:310-317.
    PubMed     Text format     Abstract available


    April 2018
  33. EL-ZEIN M, Bouten S, Louvanto K, Gilbert L, et al
    Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    Gynecol Oncol. 2018 Apr 17. pii: S0090-8258(18)30274.
    PubMed     Text format     Abstract available


  34. HENDERSON RI, Shea-Budgell M, Healy C, Letendre A, et al
    First nations people's perspectives on barriers and supports for enhancing HPV vaccination: Foundations for sustainable, community-driven strategies.
    Gynecol Oncol. 2018;149:93-100.
    PubMed     Text format     Abstract available


  35. STAPLES JN, Wong MS, Rimel BJ
    An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.
    Gynecol Oncol. 2018;149:101-105.
    PubMed     Text format     Abstract available


    March 2018
  36. CUNNINGHAM-ERVES J, Forbes L, Ivankova N, Mayo-Gamble T, et al
    Black mother's intention to vaccinate daughters against HPV: A mixed methods approach to identify opportunities for targeted communication.
    Gynecol Oncol. 2018 Mar 24. pii: S0090-8258(18)30219.
    PubMed     Text format     Abstract available


  37. CHEN L, Luan S, Xia B, Liu Y, et al
    Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30070.
    PubMed     Text format     Abstract available


  38. MINION LE, Tewari KS
    Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
    Gynecol Oncol. 2018;148:609-621.
    PubMed     Text format     Abstract available


  39. TE GROOTENHUIS NC, Pouwer AW, de Bock GH, Hollema H, et al
    Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
    Gynecol Oncol. 2018;148:622-631.
    PubMed     Text format     Abstract available


    February 2018
  40. KANG WD, Ju UC, Kim SM
    Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Gynecol Oncol. 2018;148:305-310.
    PubMed     Text format     Abstract available


    January 2018
  41. ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
    Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
    PubMed     Text format     Abstract available


  42. DONG L, Wang MZ, Zhao XL, Feng RM, et al
    Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Gynecol Oncol. 2018;148:103-110.
    PubMed     Text format     Abstract available


    December 2017
  43. XIANG L, Jiang W, Ye S, He T, et al
    ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
    PubMed     Text format     Abstract available


  44. MONTEALEGRE JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, et al
    Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
    Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31597.
    PubMed     Text format     Abstract available


  45. CASTLE PE, Pierz A, Stoler MH
    A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.
    Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31548.
    PubMed     Text format     Abstract available


  46. DILLEY S, Miller K, Huh W
    HPV vaccination.
    Gynecol Oncol. 2017 Dec 12. pii: S0090-8258(17)31547.
    PubMed     Text format    


  47. MAHANTSHETTY U, Teni T, Naga P, Hotwani C, et al
    Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
    Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31544.
    PubMed     Text format     Abstract available


    November 2017
  48. CHOLLI P, Bradford L, Manga S, Nulah K, et al
    Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31497.
    PubMed     Text format     Abstract available


  49. CHONG GO, Lee YH, Han HS, Lee HJ, et al
    Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31498.
    PubMed     Text format     Abstract available


  50. LIE AK, Trope A, Skare GB, Bjorge T, et al
    HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Gynecol Oncol. 2017 Nov 11. pii: S0090-8258(17)31453.
    PubMed     Text format     Abstract available


  51. SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
    The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
    PubMed     Text format     Abstract available


    October 2017
  52. DE LIMA MAP, Neto PJN, Lima LPM, Goncalves Junior J, et al
    Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis.
    Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31366.
    PubMed     Text format     Abstract available


    August 2017
  53. HARPER DM, DeMars LR
    Corrigendum to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017) 196-204].
    Gynecol Oncol. 2017 Aug 24. pii: S0090-8258(17)31257.
    PubMed     Text format    


  54. LURIE S, Mizrachi Y, Chodick G, Katz R, et al
    Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Gynecol Oncol. 2017;146:299-304.
    PubMed     Text format     Abstract available


  55. KASHOFER K, Regauer S
    Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Gynecol Oncol. 2017;146:314-318.
    PubMed     Text format     Abstract available


    June 2017
  56. CASTLE PE, Kinney WK, Cheung LC, Gage JC, et al
    Why does cervical cancer occur in a state-of-the-art screening program?
    Gynecol Oncol. 2017 Jun 10. pii: S0090-8258(17)30898.
    PubMed     Text format     Abstract available


    May 2017
  57. BRINTON LA, Thistle JE, Liao LM, Trabert B, et al
    Epidemiology of vulvar neoplasia in the NIH-AARP Study.
    Gynecol Oncol. 2017;145:298-304.
    PubMed     Text format     Abstract available


    April 2017
  58. HARPER DM, DeMars LR
    HPV vaccines - A review of the first decade.
    Gynecol Oncol. 2017 Apr 22. pii: S0090-8258(17)30774.
    PubMed     Text format     Abstract available


    March 2017
  59. RADER JS, Sill MW, Beumer JH, Lankes HA, et al
    A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Mar 9. pii: S0090-8258(17)30161.
    PubMed     Text format     Abstract available


    February 2017
  60. LAIRSON DR, Fu S, Chan W, Xu L, et al
    Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Gynecol Oncol. 2017 Feb 10. pii: S0090-8258(17)30122.
    PubMed     Text format     Abstract available


  61. VERLOOP J, van Leeuwen FE, Helmerhorst TJ, de Kok IM, et al
    Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
    Gynecol Oncol. 2017;144:305-311.
    PubMed     Text format     Abstract available


    January 2017
  62. WRIGHT TC JR, Behrens CM, Ranger-Moore J, Rehm S, et al
    Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Gynecol Oncol. 2017;144:51-56.
    PubMed     Text format     Abstract available


    November 2016
  63. KUJI S, Watanabe R, Sato Y, Iwata T, et al
    A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31576.
    PubMed     Text format     Abstract available


    June 2016
  64. CRONIN B, Bregar A, Luis C, Schechter S, et al
    Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.
    Gynecol Oncol. 2016;141:492-6.
    PubMed     Text format     Abstract available


    May 2016
  65. KHAN MJ, Massad LS, Kinney W, Gold MA, et al
    A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.
    Gynecol Oncol. 2016;141:364-70.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: